Timothy Walsh - Curriculum Vitae#


Univerity of Oxford
Ineos Institute at Oxford

  • Active collaborations in China, Vietnam, Thailand, Laos, Nigeria, Niger, Pakistan, Bangladesh, Brazil, Kenya, Sierra Leone, Mozambique, Rwanda, Ethiopia, and Egypt
  • Honorary Chair at Chinese Agricultural University, Beijing
  • Director of BALANCE (clinical and economic burden of AMR in LMICs)
  • Director of BARNARDS (neonatal sepsis and mortality)

Advisory boards
  • Honorary Chair at Chinese Agricultural University, Beijing
  • AMR Advisor to the United Nations
  • International Engagement Officer for British Society of Antimicrobial Chemotherapy
  • Director of BARNARDS (Burden of Antimicrobial Resistance in Neonates in Developing Societies) AMR infections in neonates funded by Gates Foundation)
  • Senior Consultant to the Fleming Fund (Mott MacDonald/DoH)[2017-2023]]
  • Advisor to the Chinese CDC
  • Advisor to the Chinese DoH and DoA
  • Advisor to the ECDC
  • Advisor and Collaborator to Médecins Sans Frontières
  • Co-ordinator and presenter of European workshops “HEAR”
  • Committee member of Children's Antibiotic Resistant infections in Low-Income countries: an international cohort study (BIRDY)

Selected Research Grant Income
  • 2021 - 2026 INEOS Institute of Antimicrobial Research, Oxford. I am Biology lead and Co-director of the IOI (£100M)
  • 2020 - 2023 Wellcome Trust. COVID and AMR (£1.0M)
  • 2019 - 2023 MRC-NSFC. DXC (DETER-XDR-China)-HUB. £2.9M (MR/S013768/1)
  • 2018 - 2022 BBSRC/MOST/NFSC. CUT-SEC (China/UK/Thailand Program on Poultry Biosafety for Salmonella, E. coli and Campylobacter (CUT-SEC). £2.4M (BB/R012776/1)
  • 2016 - 2022 NSFC/MRC – DETER-XDR-CHINA (£1.3M)

Imprint Privacy policy « This page (revision-4) was last changed on Thursday, 14. September 2023, 16:01 by System
  • operated by